EAS Publications

Free

2.0.4for iPhone, iPad

EAS Publications

Developer

Nov 18, 2019

Update Date

Medical

Category

App Store

Age Rating

Apps in this category do not contain restricted content.

Apps in this category may contain mild or occasional cartoon, fantasy or real-life violence, as well as occasional or mild adult, sexually suggestive or horrifying content and may not be suitable for children under 9 years of age.

12+

Apps in this category may contain occasional mild indecent language, frequent or intense cartoon or real-life violence, minor or occasional adult or sexually suggestive material, and simulated gambling, and may be for children under 12 years of age.

17+

You must be at least 17 years old to access this App.

Apps in this category may contain frequent and intense offensive language; Frequent and intense cartoon, fantasy or realistic violence: frequent and intense adult, scary and sexually suggestive subjects: as well as sexual content, nudity, tobacco, alcohol and drugs, may not be suitable for children under 17 years of age.

EAS Publications Screenshots

iPad

iPhone

About EAS Publications

EAS brings together expert opinions and cutting-edge research in the field of atherosclerosis and cardiovascular disease. In our new app we give you easy access to clinician’s handbooks, consensus papers and guidelines. Among the features you will find offline access, search, bookmarking, PDF download single page or the full publication, and sharing.

The European Atherosclerosis Society (EAS) was founded in 1964 with the aim of “advancing and exchanging knowledge concerning the causes, natural history, treatment and prevention of atherosclerotic disease”.
For more than 50 years the Society’s expertise has been used to teach clinicians how to manage lipid disorders and how to prevent atherosclerosis. By offering access to educational materials, and opportunities to take part in Congress and courses, and by providing a forum in which new developments can be discussed, EAS contributes to the development of knowledge in the field, and ultimately to the improved treatment of persons with cardiovascular disease and lipid disorders.

In recent years the Society has made a particular effort to recruit young scientists and clinicians also from other related disciplines.